nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocortisone—ABCG2—Dactinomycin—sarcoma	0.0967	0.132	CbGbCtD
Hydrocortisone—ABCG2—Mitoxantrone—sarcoma	0.0865	0.118	CbGbCtD
Hydrocortisone—ABCG2—Vincristine—sarcoma	0.0595	0.0815	CbGbCtD
Hydrocortisone—ABCG2—Etoposide—sarcoma	0.0546	0.0747	CbGbCtD
Hydrocortisone—CYP3A7—Vincristine—sarcoma	0.044	0.0602	CbGbCtD
Hydrocortisone—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.044	0.0602	CbGbCtD
Hydrocortisone—CYP3A4—Thiotepa—sarcoma	0.0435	0.0595	CbGbCtD
Hydrocortisone—ABCG2—Doxorubicin—sarcoma	0.0372	0.051	CbGbCtD
Hydrocortisone—ABCB1—Dactinomycin—sarcoma	0.0349	0.0477	CbGbCtD
Hydrocortisone—CYP3A5—Vincristine—sarcoma	0.033	0.0452	CbGbCtD
Hydrocortisone—ABCB1—Mitoxantrone—sarcoma	0.0312	0.0427	CbGbCtD
Hydrocortisone—CYP3A5—Etoposide—sarcoma	0.0302	0.0414	CbGbCtD
Hydrocortisone—CYP2C8—Etoposide—sarcoma	0.0291	0.0398	CbGbCtD
Hydrocortisone—ABCB1—Vincristine—sarcoma	0.0215	0.0294	CbGbCtD
Hydrocortisone—ABCB1—Etoposide—sarcoma	0.0197	0.0269	CbGbCtD
Hydrocortisone—CYP3A4—Mitoxantrone—sarcoma	0.0187	0.0256	CbGbCtD
Hydrocortisone—ABCB1—Doxorubicin—sarcoma	0.0134	0.0184	CbGbCtD
Hydrocortisone—CYP3A4—Vincristine—sarcoma	0.0129	0.0176	CbGbCtD
Hydrocortisone—CYP3A4—Etoposide—sarcoma	0.0118	0.0161	CbGbCtD
Hydrocortisone—CYP3A4—Doxorubicin—sarcoma	0.00804	0.011	CbGbCtD
Hydrocortisone—SHBG—hindlimb—sarcoma	0.00473	0.0755	CbGeAlD
Hydrocortisone—ANXA1—mammary gland—sarcoma	0.00295	0.0472	CbGeAlD
Hydrocortisone—CYP11B2—hematopoietic system—sarcoma	0.00264	0.0422	CbGeAlD
Hydrocortisone—CYP11B1—hematopoietic system—sarcoma	0.00264	0.0422	CbGeAlD
Hydrocortisone—ANXA1—myometrium—sarcoma	0.0021	0.0335	CbGeAlD
Hydrocortisone—ANXA1—embryo—sarcoma	0.00202	0.0322	CbGeAlD
Hydrocortisone—ANXA1—seminal vesicle—sarcoma	0.00189	0.0302	CbGeAlD
Hydrocortisone—ANXA1—hematopoietic system—sarcoma	0.0018	0.0287	CbGeAlD
Hydrocortisone—ANXA1—connective tissue—sarcoma	0.00173	0.0277	CbGeAlD
Hydrocortisone—ANXA1—smooth muscle tissue—sarcoma	0.00159	0.0253	CbGeAlD
Hydrocortisone—ANXA1—skin of body—sarcoma	0.00156	0.025	CbGeAlD
Hydrocortisone—ANXA1—cardiac atrium—sarcoma	0.00137	0.0218	CbGeAlD
Hydrocortisone—ANXA1—uterus—sarcoma	0.00136	0.0217	CbGeAlD
Hydrocortisone—ANXA1—lymphoid tissue—sarcoma	0.00127	0.0202	CbGeAlD
Hydrocortisone—SHBG—hematopoietic system—sarcoma	0.0012	0.0192	CbGeAlD
Hydrocortisone—ANXA1—tendon—sarcoma	0.00119	0.019	CbGeAlD
Hydrocortisone—SHBG—connective tissue—sarcoma	0.00116	0.0185	CbGeAlD
Hydrocortisone—ANXA1—bone marrow—sarcoma	0.00115	0.0184	CbGeAlD
Hydrocortisone—CYP2C8—mammary gland—sarcoma	0.00115	0.0183	CbGeAlD
Hydrocortisone—CYP11B2—lymph node—sarcoma	0.00105	0.0167	CbGeAlD
Hydrocortisone—SLCO1A2—hematopoietic system—sarcoma	0.000999	0.0159	CbGeAlD
Hydrocortisone—ANXA1—testis—sarcoma	0.000986	0.0157	CbGeAlD
Hydrocortisone—ANXA1—liver—sarcoma	0.000932	0.0149	CbGeAlD
Hydrocortisone—CYP3A7—liver—sarcoma	0.000927	0.0148	CbGeAlD
Hydrocortisone—SHBG—uterus—sarcoma	0.000908	0.0145	CbGeAlD
Hydrocortisone—ABCG2—myometrium—sarcoma	0.00079	0.0126	CbGeAlD
Hydrocortisone—CYP3A7-CYP3A51P—liver—sarcoma	0.000788	0.0126	CbGeAlD
Hydrocortisone—SHBG—bone marrow—sarcoma	0.000771	0.0123	CbGeAlD
Hydrocortisone—NR3C1—myometrium—sarcoma	0.000728	0.0116	CbGeAlD
Hydrocortisone—ANXA1—lymph node—sarcoma	0.000715	0.0114	CbGeAlD
Hydrocortisone—ABCG2—seminal vesicle—sarcoma	0.000714	0.0114	CbGeAlD
Hydrocortisone—NR3C1—embryo—sarcoma	0.0007	0.0112	CbGeAlD
Hydrocortisone—CYP2C8—hematopoietic system—sarcoma	0.000698	0.0111	CbGeAlD
Hydrocortisone—SHBG—testis—sarcoma	0.000659	0.0105	CbGeAlD
Hydrocortisone—NR3C1—seminal vesicle—sarcoma	0.000658	0.0105	CbGeAlD
Hydrocortisone—CYP3A5—hematopoietic system—sarcoma	0.00063	0.0101	CbGeAlD
Hydrocortisone—NR3C1—hematopoietic system—sarcoma	0.000625	0.00998	CbGeAlD
Hydrocortisone—SHBG—liver—sarcoma	0.000623	0.00995	CbGeAlD
Hydrocortisone—NR3C1—connective tissue—sarcoma	0.000602	0.00961	CbGeAlD
Hydrocortisone—NR3C1—smooth muscle tissue—sarcoma	0.000551	0.00879	CbGeAlD
Hydrocortisone—SLCO1A2—testis—sarcoma	0.000547	0.00874	CbGeAlD
Hydrocortisone—NR3C1—skin of body—sarcoma	0.000543	0.00868	CbGeAlD
Hydrocortisone—SLCO1A2—liver—sarcoma	0.000518	0.00826	CbGeAlD
Hydrocortisone—ABCG2—uterus—sarcoma	0.000513	0.00818	CbGeAlD
Hydrocortisone—SHBG—Nongenotropic Androgen signaling—PLCG1—sarcoma	0.000512	0.0835	CbGpPWpGaD
Hydrocortisone—NR3C1—cardiac atrium—sarcoma	0.000475	0.00758	CbGeAlD
Hydrocortisone—CYP3A4—hematopoietic system—sarcoma	0.000473	0.00755	CbGeAlD
Hydrocortisone—NR3C1—uterus—sarcoma	0.000472	0.00754	CbGeAlD
Hydrocortisone—NR3C1—lymphoid tissue—sarcoma	0.00044	0.00703	CbGeAlD
Hydrocortisone—ABCG2—bone marrow—sarcoma	0.000435	0.00695	CbGeAlD
Hydrocortisone—NR3C1—tendon—sarcoma	0.000414	0.0066	CbGeAlD
Hydrocortisone—NR3C1—bone marrow—sarcoma	0.000401	0.0064	CbGeAlD
Hydrocortisone—ABCB1—myometrium—sarcoma	0.00039	0.00622	CbGeAlD
Hydrocortisone—CYP2C8—testis—sarcoma	0.000382	0.00611	CbGeAlD
Hydrocortisone—ABCB1—embryo—sarcoma	0.000375	0.00598	CbGeAlD
Hydrocortisone—ABCG2—testis—sarcoma	0.000372	0.00594	CbGeAlD
Hydrocortisone—CYP2C8—liver—sarcoma	0.000362	0.00577	CbGeAlD
Hydrocortisone—ABCB1—seminal vesicle—sarcoma	0.000352	0.00562	CbGeAlD
Hydrocortisone—ABCG2—liver—sarcoma	0.000352	0.00561	CbGeAlD
Hydrocortisone—NR3C1—testis—sarcoma	0.000343	0.00547	CbGeAlD
Hydrocortisone—ABCB1—hematopoietic system—sarcoma	0.000335	0.00534	CbGeAlD
Hydrocortisone—CYP3A5—liver—sarcoma	0.000326	0.00521	CbGeAlD
Hydrocortisone—NR3C1—liver—sarcoma	0.000324	0.00517	CbGeAlD
Hydrocortisone—Lethargy—Epirubicin—sarcoma	0.000293	0.00146	CcSEcCtD
Hydrocortisone—Cardiac failure congestive—Doxorubicin—sarcoma	0.000293	0.00146	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Mitoxantrone—sarcoma	0.000293	0.00146	CcSEcCtD
Hydrocortisone—Hypotension—Vincristine—sarcoma	0.000291	0.00145	CcSEcCtD
Hydrocortisone—Feeling abnormal—Thiotepa—sarcoma	0.000289	0.00144	CcSEcCtD
Hydrocortisone—Anorexia—Mitoxantrone—sarcoma	0.000289	0.00144	CcSEcCtD
Hydrocortisone—Osteoarthritis—Epirubicin—sarcoma	0.000288	0.00143	CcSEcCtD
Hydrocortisone—Feeling abnormal—Dactinomycin—sarcoma	0.000287	0.00143	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Thiotepa—sarcoma	0.000287	0.00143	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Etoposide—sarcoma	0.000287	0.00143	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Dactinomycin—sarcoma	0.000285	0.00142	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Vincristine—sarcoma	0.000284	0.00141	CcSEcCtD
Hydrocortisone—Hypotension—Mitoxantrone—sarcoma	0.000283	0.00141	CcSEcCtD
Hydrocortisone—Increased appetite—Doxorubicin—sarcoma	0.000283	0.00141	CcSEcCtD
Hydrocortisone—Affect lability—Epirubicin—sarcoma	0.000283	0.00141	CcSEcCtD
Hydrocortisone—Insomnia—Vincristine—sarcoma	0.000281	0.0014	CcSEcCtD
Hydrocortisone—Paraesthesia—Vincristine—sarcoma	0.000279	0.00139	CcSEcCtD
Hydrocortisone—Urticaria—Thiotepa—sarcoma	0.000279	0.00139	CcSEcCtD
Hydrocortisone—Malaise—Etoposide—sarcoma	0.000279	0.00139	CcSEcCtD
Hydrocortisone—Vertigo—Etoposide—sarcoma	0.000278	0.00138	CcSEcCtD
Hydrocortisone—Abdominal pain—Thiotepa—sarcoma	0.000277	0.00138	CcSEcCtD
Hydrocortisone—Body temperature increased—Thiotepa—sarcoma	0.000277	0.00138	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000276	0.00137	CcSEcCtD
Hydrocortisone—Abdominal pain—Dactinomycin—sarcoma	0.000275	0.00137	CcSEcCtD
Hydrocortisone—Body temperature increased—Dactinomycin—sarcoma	0.000275	0.00137	CcSEcCtD
Hydrocortisone—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000275	0.00137	CcSEcCtD
Hydrocortisone—Cardiac arrest—Epirubicin—sarcoma	0.000273	0.00136	CcSEcCtD
Hydrocortisone—Cardiac failure—Doxorubicin—sarcoma	0.000273	0.00136	CcSEcCtD
Hydrocortisone—Mood swings—Epirubicin—sarcoma	0.000272	0.00135	CcSEcCtD
Hydrocortisone—Paraesthesia—Mitoxantrone—sarcoma	0.000272	0.00135	CcSEcCtD
Hydrocortisone—Loss of consciousness—Etoposide—sarcoma	0.000271	0.00135	CcSEcCtD
Hydrocortisone—Lethargy—Doxorubicin—sarcoma	0.000271	0.00135	CcSEcCtD
Hydrocortisone—Decreased appetite—Vincristine—sarcoma	0.000271	0.00135	CcSEcCtD
Hydrocortisone—ABCG2—lymph node—sarcoma	0.00027	0.0043	CbGeAlD
Hydrocortisone—Gastrointestinal disorder—Vincristine—sarcoma	0.000269	0.00134	CcSEcCtD
Hydrocortisone—Fatigue—Vincristine—sarcoma	0.000268	0.00133	CcSEcCtD
Hydrocortisone—Convulsion—Etoposide—sarcoma	0.000268	0.00133	CcSEcCtD
Hydrocortisone—Dyspepsia—Mitoxantrone—sarcoma	0.000267	0.00133	CcSEcCtD
Hydrocortisone—Hypertension—Etoposide—sarcoma	0.000267	0.00133	CcSEcCtD
Hydrocortisone—Pain—Vincristine—sarcoma	0.000266	0.00132	CcSEcCtD
Hydrocortisone—Osteoarthritis—Doxorubicin—sarcoma	0.000266	0.00132	CcSEcCtD
Hydrocortisone—Dry skin—Epirubicin—sarcoma	0.000264	0.00131	CcSEcCtD
Hydrocortisone—Decreased appetite—Mitoxantrone—sarcoma	0.000263	0.00131	CcSEcCtD
Hydrocortisone—SHBG—Nongenotropic Androgen signaling—CREB1—sarcoma	0.000263	0.043	CbGpPWpGaD
Hydrocortisone—Abdominal pain upper—Epirubicin—sarcoma	0.000263	0.00131	CcSEcCtD
Hydrocortisone—Affect lability—Doxorubicin—sarcoma	0.000262	0.0013	CcSEcCtD
Hydrocortisone—Hypokalaemia—Epirubicin—sarcoma	0.000262	0.0013	CcSEcCtD
Hydrocortisone—Fatigue—Mitoxantrone—sarcoma	0.000261	0.0013	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000261	0.0013	CcSEcCtD
Hydrocortisone—Discomfort—Etoposide—sarcoma	0.00026	0.00129	CcSEcCtD
Hydrocortisone—Pain—Mitoxantrone—sarcoma	0.000259	0.00129	CcSEcCtD
Hydrocortisone—Hypersensitivity—Thiotepa—sarcoma	0.000259	0.00129	CcSEcCtD
Hydrocortisone—Hypersensitivity—Dactinomycin—sarcoma	0.000257	0.00128	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Vincristine—sarcoma	0.000254	0.00127	CcSEcCtD
Hydrocortisone—Muscular weakness—Epirubicin—sarcoma	0.000254	0.00126	CcSEcCtD
Hydrocortisone—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000254	0.00126	CcSEcCtD
Hydrocortisone—Cardiac arrest—Doxorubicin—sarcoma	0.000253	0.00126	CcSEcCtD
Hydrocortisone—ABCB1—uterus—sarcoma	0.000253	0.00404	CbGeAlD
Hydrocortisone—Anaphylactic shock—Etoposide—sarcoma	0.000252	0.00125	CcSEcCtD
Hydrocortisone—Mood swings—Doxorubicin—sarcoma	0.000252	0.00125	CcSEcCtD
Hydrocortisone—Asthenia—Thiotepa—sarcoma	0.000252	0.00125	CcSEcCtD
Hydrocortisone—Infection—Etoposide—sarcoma	0.00025	0.00125	CcSEcCtD
Hydrocortisone—Abdominal distension—Epirubicin—sarcoma	0.00025	0.00124	CcSEcCtD
Hydrocortisone—Asthenia—Dactinomycin—sarcoma	0.00025	0.00124	CcSEcCtD
Hydrocortisone—Feeling abnormal—Mitoxantrone—sarcoma	0.00025	0.00124	CcSEcCtD
Hydrocortisone—Pruritus—Thiotepa—sarcoma	0.000248	0.00123	CcSEcCtD
Hydrocortisone—NR3C1—lymph node—sarcoma	0.000248	0.00396	CbGeAlD
Hydrocortisone—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000248	0.00123	CcSEcCtD
Hydrocortisone—Tachycardia—Etoposide—sarcoma	0.000246	0.00122	CcSEcCtD
Hydrocortisone—Abdominal pain—Vincristine—sarcoma	0.000246	0.00122	CcSEcCtD
Hydrocortisone—Body temperature increased—Vincristine—sarcoma	0.000246	0.00122	CcSEcCtD
Hydrocortisone—CYP3A4—liver—sarcoma	0.000245	0.00391	CbGeAlD
Hydrocortisone—Skin disorder—Etoposide—sarcoma	0.000245	0.00122	CcSEcCtD
Hydrocortisone—Dry skin—Doxorubicin—sarcoma	0.000244	0.00121	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Etoposide—sarcoma	0.000244	0.00121	CcSEcCtD
Hydrocortisone—Pancreatitis—Epirubicin—sarcoma	0.000244	0.00121	CcSEcCtD
Hydrocortisone—Abdominal pain upper—Doxorubicin—sarcoma	0.000243	0.00121	CcSEcCtD
Hydrocortisone—Hypokalaemia—Doxorubicin—sarcoma	0.000242	0.0012	CcSEcCtD
Hydrocortisone—Urticaria—Mitoxantrone—sarcoma	0.000241	0.0012	CcSEcCtD
Hydrocortisone—Anorexia—Etoposide—sarcoma	0.00024	0.0012	CcSEcCtD
Hydrocortisone—Diarrhoea—Thiotepa—sarcoma	0.00024	0.00119	CcSEcCtD
Hydrocortisone—Body temperature increased—Mitoxantrone—sarcoma	0.00024	0.00119	CcSEcCtD
Hydrocortisone—Abdominal pain—Mitoxantrone—sarcoma	0.00024	0.00119	CcSEcCtD
Hydrocortisone—Diarrhoea—Dactinomycin—sarcoma	0.000238	0.00119	CcSEcCtD
Hydrocortisone—ABCB1—lymphoid tissue—sarcoma	0.000236	0.00376	CbGeAlD
Hydrocortisone—Hypotension—Etoposide—sarcoma	0.000236	0.00117	CcSEcCtD
Hydrocortisone—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000235	0.00117	CcSEcCtD
Hydrocortisone—Muscular weakness—Doxorubicin—sarcoma	0.000235	0.00117	CcSEcCtD
Hydrocortisone—Dizziness—Thiotepa—sarcoma	0.000232	0.00115	CcSEcCtD
Hydrocortisone—Abdominal distension—Doxorubicin—sarcoma	0.000231	0.00115	CcSEcCtD
Hydrocortisone—Upper respiratory tract infection—Epirubicin—sarcoma	0.000231	0.00115	CcSEcCtD
Hydrocortisone—Hypersensitivity—Vincristine—sarcoma	0.000229	0.00114	CcSEcCtD
Hydrocortisone—Paraesthesia—Etoposide—sarcoma	0.000226	0.00113	CcSEcCtD
Hydrocortisone—Weight increased—Epirubicin—sarcoma	0.000226	0.00112	CcSEcCtD
Hydrocortisone—Pancreatitis—Doxorubicin—sarcoma	0.000225	0.00112	CcSEcCtD
Hydrocortisone—Weight decreased—Epirubicin—sarcoma	0.000225	0.00112	CcSEcCtD
Hydrocortisone—Hypersensitivity—Mitoxantrone—sarcoma	0.000223	0.00111	CcSEcCtD
Hydrocortisone—Asthenia—Vincristine—sarcoma	0.000223	0.00111	CcSEcCtD
Hydrocortisone—Vomiting—Thiotepa—sarcoma	0.000223	0.00111	CcSEcCtD
Hydrocortisone—Infestation NOS—Epirubicin—sarcoma	0.000222	0.0011	CcSEcCtD
Hydrocortisone—Infestation—Epirubicin—sarcoma	0.000222	0.0011	CcSEcCtD
Hydrocortisone—Vomiting—Dactinomycin—sarcoma	0.000221	0.0011	CcSEcCtD
Hydrocortisone—Rash—Thiotepa—sarcoma	0.000221	0.0011	CcSEcCtD
Hydrocortisone—Dermatitis—Thiotepa—sarcoma	0.000221	0.0011	CcSEcCtD
Hydrocortisone—Headache—Thiotepa—sarcoma	0.00022	0.00109	CcSEcCtD
Hydrocortisone—Rash—Dactinomycin—sarcoma	0.00022	0.00109	CcSEcCtD
Hydrocortisone—Decreased appetite—Etoposide—sarcoma	0.000219	0.00109	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Etoposide—sarcoma	0.000218	0.00108	CcSEcCtD
Hydrocortisone—Asthenia—Mitoxantrone—sarcoma	0.000217	0.00108	CcSEcCtD
Hydrocortisone—Fatigue—Etoposide—sarcoma	0.000217	0.00108	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Epirubicin—sarcoma	0.000217	0.00108	CcSEcCtD
Hydrocortisone—Pain—Etoposide—sarcoma	0.000216	0.00107	CcSEcCtD
Hydrocortisone—ABCB1—bone marrow—sarcoma	0.000215	0.00342	CbGeAlD
Hydrocortisone—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000214	0.00106	CcSEcCtD
Hydrocortisone—Diarrhoea—Vincristine—sarcoma	0.000213	0.00106	CcSEcCtD
Hydrocortisone—Weight increased—Doxorubicin—sarcoma	0.000209	0.00104	CcSEcCtD
Hydrocortisone—Nausea—Thiotepa—sarcoma	0.000208	0.00104	CcSEcCtD
Hydrocortisone—Weight decreased—Doxorubicin—sarcoma	0.000208	0.00103	CcSEcCtD
Hydrocortisone—Feeling abnormal—Etoposide—sarcoma	0.000208	0.00103	CcSEcCtD
Hydrocortisone—Diarrhoea—Mitoxantrone—sarcoma	0.000207	0.00103	CcSEcCtD
Hydrocortisone—Nausea—Dactinomycin—sarcoma	0.000207	0.00103	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Etoposide—sarcoma	0.000206	0.00103	CcSEcCtD
Hydrocortisone—Dizziness—Vincristine—sarcoma	0.000206	0.00102	CcSEcCtD
Hydrocortisone—Infestation NOS—Doxorubicin—sarcoma	0.000205	0.00102	CcSEcCtD
Hydrocortisone—Infestation—Doxorubicin—sarcoma	0.000205	0.00102	CcSEcCtD
Hydrocortisone—Bradycardia—Epirubicin—sarcoma	0.000202	0.00101	CcSEcCtD
Hydrocortisone—Neuropathy peripheral—Doxorubicin—sarcoma	0.000201	0.000999	CcSEcCtD
Hydrocortisone—Urticaria—Etoposide—sarcoma	0.0002	0.000996	CcSEcCtD
Hydrocortisone—Haemoglobin—Epirubicin—sarcoma	0.0002	0.000994	CcSEcCtD
Hydrocortisone—Body temperature increased—Etoposide—sarcoma	0.000199	0.000991	CcSEcCtD
Hydrocortisone—Abdominal pain—Etoposide—sarcoma	0.000199	0.000991	CcSEcCtD
Hydrocortisone—Haemorrhage—Epirubicin—sarcoma	0.000199	0.000989	CcSEcCtD
Hydrocortisone—Vomiting—Vincristine—sarcoma	0.000198	0.000984	CcSEcCtD
Hydrocortisone—Rash—Vincristine—sarcoma	0.000196	0.000976	CcSEcCtD
Hydrocortisone—Dermatitis—Vincristine—sarcoma	0.000196	0.000975	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Epirubicin—sarcoma	0.000195	0.000972	CcSEcCtD
Hydrocortisone—Headache—Vincristine—sarcoma	0.000195	0.00097	CcSEcCtD
Hydrocortisone—Vomiting—Mitoxantrone—sarcoma	0.000193	0.000958	CcSEcCtD
Hydrocortisone—Rash—Mitoxantrone—sarcoma	0.000191	0.00095	CcSEcCtD
Hydrocortisone—Dermatitis—Mitoxantrone—sarcoma	0.000191	0.00095	CcSEcCtD
Hydrocortisone—Headache—Mitoxantrone—sarcoma	0.00019	0.000944	CcSEcCtD
Hydrocortisone—Bradycardia—Doxorubicin—sarcoma	0.000187	0.000932	CcSEcCtD
Hydrocortisone—Eye disorder—Epirubicin—sarcoma	0.000186	0.000925	CcSEcCtD
Hydrocortisone—Hypersensitivity—Etoposide—sarcoma	0.000186	0.000924	CcSEcCtD
Hydrocortisone—Haemoglobin—Doxorubicin—sarcoma	0.000185	0.00092	CcSEcCtD
Hydrocortisone—Nausea—Vincristine—sarcoma	0.000185	0.000919	CcSEcCtD
Hydrocortisone—Haemorrhage—Doxorubicin—sarcoma	0.000184	0.000915	CcSEcCtD
Hydrocortisone—ABCB1—testis—sarcoma	0.000183	0.00293	CbGeAlD
Hydrocortisone—Asthenia—Etoposide—sarcoma	0.000181	0.0009	CcSEcCtD
Hydrocortisone—Connective tissue disorder—Doxorubicin—sarcoma	0.000181	0.000899	CcSEcCtD
Hydrocortisone—Nausea—Mitoxantrone—sarcoma	0.00018	0.000895	CcSEcCtD
Hydrocortisone—Immune system disorder—Epirubicin—sarcoma	0.00018	0.000894	CcSEcCtD
Hydrocortisone—Pruritus—Etoposide—sarcoma	0.000178	0.000887	CcSEcCtD
Hydrocortisone—Arrhythmia—Epirubicin—sarcoma	0.000178	0.000884	CcSEcCtD
Hydrocortisone—Mental disorder—Epirubicin—sarcoma	0.000174	0.000867	CcSEcCtD
Hydrocortisone—ABCB1—liver—sarcoma	0.000173	0.00277	CbGeAlD
Hydrocortisone—Erythema—Epirubicin—sarcoma	0.000173	0.000861	CcSEcCtD
Hydrocortisone—Malnutrition—Epirubicin—sarcoma	0.000173	0.000861	CcSEcCtD
Hydrocortisone—Diarrhoea—Etoposide—sarcoma	0.000172	0.000858	CcSEcCtD
Hydrocortisone—Eye disorder—Doxorubicin—sarcoma	0.000172	0.000855	CcSEcCtD
Hydrocortisone—SHBG—Nongenotropic Androgen signaling—SRC—sarcoma	0.00017	0.0277	CbGpPWpGaD
Hydrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—ATF1—sarcoma	0.000169	0.0276	CbGpPWpGaD
Hydrocortisone—Dizziness—Etoposide—sarcoma	0.000167	0.000829	CcSEcCtD
Hydrocortisone—Immune system disorder—Doxorubicin—sarcoma	0.000166	0.000827	CcSEcCtD
Hydrocortisone—Arrhythmia—Doxorubicin—sarcoma	0.000164	0.000818	CcSEcCtD
Hydrocortisone—Mental disorder—Doxorubicin—sarcoma	0.000161	0.000802	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Epirubicin—sarcoma	0.000161	0.000799	CcSEcCtD
Hydrocortisone—Vomiting—Etoposide—sarcoma	0.00016	0.000797	CcSEcCtD
Hydrocortisone—Erythema—Doxorubicin—sarcoma	0.00016	0.000797	CcSEcCtD
Hydrocortisone—Malnutrition—Doxorubicin—sarcoma	0.00016	0.000797	CcSEcCtD
Hydrocortisone—Rash—Etoposide—sarcoma	0.000159	0.000791	CcSEcCtD
Hydrocortisone—Dermatitis—Etoposide—sarcoma	0.000159	0.00079	CcSEcCtD
Hydrocortisone—Headache—Etoposide—sarcoma	0.000158	0.000785	CcSEcCtD
Hydrocortisone—Malaise—Epirubicin—sarcoma	0.000156	0.000777	CcSEcCtD
Hydrocortisone—Vertigo—Epirubicin—sarcoma	0.000156	0.000774	CcSEcCtD
Hydrocortisone—Syncope—Epirubicin—sarcoma	0.000155	0.000772	CcSEcCtD
Hydrocortisone—Loss of consciousness—Epirubicin—sarcoma	0.000152	0.000757	CcSEcCtD
Hydrocortisone—Convulsion—Epirubicin—sarcoma	0.00015	0.000746	CcSEcCtD
Hydrocortisone—Nausea—Etoposide—sarcoma	0.00015	0.000745	CcSEcCtD
Hydrocortisone—Hypertension—Epirubicin—sarcoma	0.000149	0.000744	CcSEcCtD
Hydrocortisone—Ill-defined disorder—Doxorubicin—sarcoma	0.000149	0.000739	CcSEcCtD
Hydrocortisone—Myalgia—Epirubicin—sarcoma	0.000147	0.000733	CcSEcCtD
Hydrocortisone—Anxiety—Epirubicin—sarcoma	0.000147	0.000731	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000146	0.000728	CcSEcCtD
Hydrocortisone—Discomfort—Epirubicin—sarcoma	0.000146	0.000724	CcSEcCtD
Hydrocortisone—Malaise—Doxorubicin—sarcoma	0.000144	0.000719	CcSEcCtD
Hydrocortisone—Vertigo—Doxorubicin—sarcoma	0.000144	0.000716	CcSEcCtD
Hydrocortisone—Syncope—Doxorubicin—sarcoma	0.000144	0.000715	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Epirubicin—sarcoma	0.000141	0.000703	CcSEcCtD
Hydrocortisone—Oedema—Epirubicin—sarcoma	0.000141	0.000703	CcSEcCtD
Hydrocortisone—Loss of consciousness—Doxorubicin—sarcoma	0.000141	0.0007	CcSEcCtD
Hydrocortisone—Infection—Epirubicin—sarcoma	0.00014	0.000698	CcSEcCtD
Hydrocortisone—Shock—Epirubicin—sarcoma	0.000139	0.000691	CcSEcCtD
Hydrocortisone—Convulsion—Doxorubicin—sarcoma	0.000139	0.00069	CcSEcCtD
Hydrocortisone—Nervous system disorder—Epirubicin—sarcoma	0.000139	0.000689	CcSEcCtD
Hydrocortisone—Hypertension—Doxorubicin—sarcoma	0.000138	0.000688	CcSEcCtD
Hydrocortisone—Tachycardia—Epirubicin—sarcoma	0.000138	0.000686	CcSEcCtD
Hydrocortisone—Skin disorder—Epirubicin—sarcoma	0.000137	0.000683	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Epirubicin—sarcoma	0.000137	0.000679	CcSEcCtD
Hydrocortisone—Myalgia—Doxorubicin—sarcoma	0.000136	0.000678	CcSEcCtD
Hydrocortisone—Anxiety—Doxorubicin—sarcoma	0.000136	0.000676	CcSEcCtD
Hydrocortisone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000135	0.000674	CcSEcCtD
Hydrocortisone—Discomfort—Doxorubicin—sarcoma	0.000135	0.00067	CcSEcCtD
Hydrocortisone—Anorexia—Epirubicin—sarcoma	0.000135	0.00067	CcSEcCtD
Hydrocortisone—ABCB1—lymph node—sarcoma	0.000133	0.00212	CbGeAlD
Hydrocortisone—Hypotension—Epirubicin—sarcoma	0.000132	0.000657	CcSEcCtD
Hydrocortisone—Oedema—Doxorubicin—sarcoma	0.000131	0.00065	CcSEcCtD
Hydrocortisone—Anaphylactic shock—Doxorubicin—sarcoma	0.000131	0.00065	CcSEcCtD
Hydrocortisone—Infection—Doxorubicin—sarcoma	0.00013	0.000646	CcSEcCtD
Hydrocortisone—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000129	0.00064	CcSEcCtD
Hydrocortisone—Shock—Doxorubicin—sarcoma	0.000129	0.00064	CcSEcCtD
Hydrocortisone—Nervous system disorder—Doxorubicin—sarcoma	0.000128	0.000638	CcSEcCtD
Hydrocortisone—Insomnia—Epirubicin—sarcoma	0.000128	0.000636	CcSEcCtD
Hydrocortisone—Tachycardia—Doxorubicin—sarcoma	0.000128	0.000635	CcSEcCtD
Hydrocortisone—Skin disorder—Doxorubicin—sarcoma	0.000127	0.000632	CcSEcCtD
Hydrocortisone—Paraesthesia—Epirubicin—sarcoma	0.000127	0.000631	CcSEcCtD
Hydrocortisone—Hyperhidrosis—Doxorubicin—sarcoma	0.000126	0.000629	CcSEcCtD
Hydrocortisone—Anorexia—Doxorubicin—sarcoma	0.000125	0.00062	CcSEcCtD
Hydrocortisone—Dyspepsia—Epirubicin—sarcoma	0.000124	0.000619	CcSEcCtD
Hydrocortisone—Decreased appetite—Epirubicin—sarcoma	0.000123	0.000611	CcSEcCtD
Hydrocortisone—Hypotension—Doxorubicin—sarcoma	0.000122	0.000608	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Epirubicin—sarcoma	0.000122	0.000607	CcSEcCtD
Hydrocortisone—Fatigue—Epirubicin—sarcoma	0.000122	0.000606	CcSEcCtD
Hydrocortisone—Pain—Epirubicin—sarcoma	0.000121	0.000601	CcSEcCtD
Hydrocortisone—SHBG—Nongenotropic Androgen signaling—HRAS—sarcoma	0.00012	0.0195	CbGpPWpGaD
Hydrocortisone—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000119	0.000592	CcSEcCtD
Hydrocortisone—Insomnia—Doxorubicin—sarcoma	0.000118	0.000588	CcSEcCtD
Hydrocortisone—Paraesthesia—Doxorubicin—sarcoma	0.000117	0.000584	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000117	0.019	CbGpPWpGaD
Hydrocortisone—Feeling abnormal—Epirubicin—sarcoma	0.000116	0.000579	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Epirubicin—sarcoma	0.000116	0.000575	CcSEcCtD
Hydrocortisone—Dyspepsia—Doxorubicin—sarcoma	0.000115	0.000572	CcSEcCtD
Hydrocortisone—Decreased appetite—Doxorubicin—sarcoma	0.000114	0.000565	CcSEcCtD
Hydrocortisone—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000113	0.000561	CcSEcCtD
Hydrocortisone—ABCG2—HIF-2-alpha transcription factor network—FLT1—sarcoma	0.000113	0.0184	CbGpPWpGaD
Hydrocortisone—Fatigue—Doxorubicin—sarcoma	0.000113	0.000561	CcSEcCtD
Hydrocortisone—Urticaria—Epirubicin—sarcoma	0.000112	0.000558	CcSEcCtD
Hydrocortisone—NR3C1—Transcription factor regulation in adipogenesis—FOXO1—sarcoma	0.000112	0.0183	CbGpPWpGaD
Hydrocortisone—Pain—Doxorubicin—sarcoma	0.000112	0.000556	CcSEcCtD
Hydrocortisone—Abdominal pain—Epirubicin—sarcoma	0.000112	0.000556	CcSEcCtD
Hydrocortisone—Body temperature increased—Epirubicin—sarcoma	0.000112	0.000556	CcSEcCtD
Hydrocortisone—Feeling abnormal—Doxorubicin—sarcoma	0.000108	0.000536	CcSEcCtD
Hydrocortisone—Gastrointestinal pain—Doxorubicin—sarcoma	0.000107	0.000532	CcSEcCtD
Hydrocortisone—ABCG2—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000104	0.0171	CbGpPWpGaD
Hydrocortisone—Hypersensitivity—Epirubicin—sarcoma	0.000104	0.000518	CcSEcCtD
Hydrocortisone—Urticaria—Doxorubicin—sarcoma	0.000104	0.000517	CcSEcCtD
Hydrocortisone—Body temperature increased—Doxorubicin—sarcoma	0.000103	0.000514	CcSEcCtD
Hydrocortisone—Abdominal pain—Doxorubicin—sarcoma	0.000103	0.000514	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—ATF1—sarcoma	0.000102	0.0166	CbGpPWpGaD
Hydrocortisone—Asthenia—Epirubicin—sarcoma	0.000101	0.000504	CcSEcCtD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—PLCG1—sarcoma	0.000101	0.0164	CbGpPWpGaD
Hydrocortisone—Pruritus—Epirubicin—sarcoma	0.0001	0.000497	CcSEcCtD
Hydrocortisone—Diarrhoea—Epirubicin—sarcoma	9.67e-05	0.000481	CcSEcCtD
Hydrocortisone—Hypersensitivity—Doxorubicin—sarcoma	9.63e-05	0.000479	CcSEcCtD
Hydrocortisone—Asthenia—Doxorubicin—sarcoma	9.38e-05	0.000467	CcSEcCtD
Hydrocortisone—Dizziness—Epirubicin—sarcoma	9.34e-05	0.000465	CcSEcCtD
Hydrocortisone—Pruritus—Doxorubicin—sarcoma	9.25e-05	0.00046	CcSEcCtD
Hydrocortisone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—CREB1—sarcoma	9.15e-05	0.0149	CbGpPWpGaD
Hydrocortisone—Vomiting—Epirubicin—sarcoma	8.98e-05	0.000447	CcSEcCtD
Hydrocortisone—Diarrhoea—Doxorubicin—sarcoma	8.95e-05	0.000445	CcSEcCtD
Hydrocortisone—Rash—Epirubicin—sarcoma	8.91e-05	0.000443	CcSEcCtD
Hydrocortisone—Dermatitis—Epirubicin—sarcoma	8.9e-05	0.000443	CcSEcCtD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—NPM1—sarcoma	8.87e-05	0.0145	CbGpPWpGaD
Hydrocortisone—Headache—Epirubicin—sarcoma	8.85e-05	0.00044	CcSEcCtD
Hydrocortisone—Dizziness—Doxorubicin—sarcoma	8.65e-05	0.00043	CcSEcCtD
Hydrocortisone—ANXA1—Peptide ligand-binding receptors—CXCR4—sarcoma	8.56e-05	0.014	CbGpPWpGaD
Hydrocortisone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	8.42e-05	0.0137	CbGpPWpGaD
Hydrocortisone—Nausea—Epirubicin—sarcoma	8.39e-05	0.000417	CcSEcCtD
Hydrocortisone—Vomiting—Doxorubicin—sarcoma	8.31e-05	0.000413	CcSEcCtD
Hydrocortisone—Rash—Doxorubicin—sarcoma	8.24e-05	0.00041	CcSEcCtD
Hydrocortisone—Dermatitis—Doxorubicin—sarcoma	8.24e-05	0.00041	CcSEcCtD
Hydrocortisone—Headache—Doxorubicin—sarcoma	8.19e-05	0.000407	CcSEcCtD
Hydrocortisone—NR3C1—Transcription factor regulation in adipogenesis—CREB1—sarcoma	8.14e-05	0.0133	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYOD1—sarcoma	7.88e-05	0.0129	CbGpPWpGaD
Hydrocortisone—Nausea—Doxorubicin—sarcoma	7.77e-05	0.000386	CcSEcCtD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—FOXO1—sarcoma	7.6e-05	0.0124	CbGpPWpGaD
Hydrocortisone—ANXA1—G alpha (i) signalling events—CXCR4—sarcoma	7.23e-05	0.0118	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-2-alpha transcription factor network—KDR—sarcoma	6.51e-05	0.0106	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—CXCR4—sarcoma	6.27e-05	0.0102	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	6.19e-05	0.0101	CbGpPWpGaD
Hydrocortisone—CYP3A5—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	5.92e-05	0.00966	CbGpPWpGaD
Hydrocortisone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	5.86e-05	0.00957	CbGpPWpGaD
Hydrocortisone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	5.77e-05	0.00942	CbGpPWpGaD
Hydrocortisone—ANXA1—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	5.74e-05	0.00938	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of Androgen receptor activity—FOXO1—sarcoma	5.55e-05	0.00906	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—CREB1—sarcoma	5.51e-05	0.009	CbGpPWpGaD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—CREB1—sarcoma	5.18e-05	0.00846	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—IL2—sarcoma	4.96e-05	0.0081	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—CCND1—sarcoma	4.84e-05	0.0079	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—NPM1—sarcoma	4.8e-05	0.00783	CbGpPWpGaD
Hydrocortisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—sarcoma	4.67e-05	0.00763	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	4.57e-05	0.00746	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—MDM2—sarcoma	4.56e-05	0.00744	CbGpPWpGaD
Hydrocortisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	4.55e-05	0.00743	CbGpPWpGaD
Hydrocortisone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	4.48e-05	0.0073	CbGpPWpGaD
Hydrocortisone—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	4.47e-05	0.00729	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR ligand binding—CXCR4—sarcoma	4.37e-05	0.00714	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—sarcoma	4.16e-05	0.00678	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—CCND1—sarcoma	3.97e-05	0.00648	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—JUN—sarcoma	3.96e-05	0.00647	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—sarcoma	3.95e-05	0.00645	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	3.93e-05	0.00642	CbGpPWpGaD
Hydrocortisone—NR3C1—Circadian Clock—CREB1—sarcoma	3.91e-05	0.00638	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—MYC—sarcoma	3.88e-05	0.00634	CbGpPWpGaD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—IL2—sarcoma	3.83e-05	0.00625	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—EGFR—sarcoma	3.8e-05	0.0062	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	3.78e-05	0.00617	CbGpPWpGaD
Hydrocortisone—CYP11B1—Corticotropin-releasing hormone—CTNNB1—sarcoma	3.7e-05	0.00604	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-2-alpha transcription factor network—VEGFA—sarcoma	3.59e-05	0.00585	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	3.46e-05	0.00565	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—CXCR4—sarcoma	3.39e-05	0.00553	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—CREB1—sarcoma	3.36e-05	0.00548	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of Androgen receptor activity—MDM2—sarcoma	3.33e-05	0.00544	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	3.29e-05	0.00537	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	3.29e-05	0.00536	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	3.26e-05	0.00532	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—CREB1—sarcoma	3.22e-05	0.00526	CbGpPWpGaD
Hydrocortisone—ANXA1—Spinal Cord Injury—TP53—sarcoma	3.19e-05	0.0052	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—MYC—sarcoma	3.19e-05	0.0052	CbGpPWpGaD
Hydrocortisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	3.17e-05	0.00517	CbGpPWpGaD
Hydrocortisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	3.12e-05	0.00509	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—EGFR—sarcoma	3.12e-05	0.00509	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	2.95e-05	0.00481	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—KRAS—sarcoma	2.94e-05	0.00481	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of Androgen receptor activity—JUN—sarcoma	2.9e-05	0.00473	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	2.87e-05	0.00468	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—sarcoma	2.87e-05	0.00468	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CREB1—sarcoma	2.84e-05	0.00463	CbGpPWpGaD
Hydrocortisone—ABCG2—Fluoropyrimidine Activity—TP53—sarcoma	2.77e-05	0.00453	CbGpPWpGaD
Hydrocortisone—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	2.75e-05	0.00449	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—FOXO1—sarcoma	2.71e-05	0.00442	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	2.64e-05	0.00431	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Breast Cancer Pathway—TP53—sarcoma	2.62e-05	0.00427	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of Androgen receptor activity—SRC—sarcoma	2.6e-05	0.00424	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	2.58e-05	0.00422	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—sarcoma	2.58e-05	0.00421	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—CXCR4—sarcoma	2.47e-05	0.00403	CbGpPWpGaD
Hydrocortisone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	2.46e-05	0.00402	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	2.44e-05	0.00398	CbGpPWpGaD
Hydrocortisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	2.42e-05	0.00395	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—JUN—sarcoma	2.41e-05	0.00394	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—IL2—sarcoma	2.38e-05	0.00389	CbGpPWpGaD
Hydrocortisone—NR3C1—Endoderm Differentiation—CTNNB1—sarcoma	2.35e-05	0.00384	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—sarcoma	2.35e-05	0.00383	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—sarcoma	2.35e-05	0.00383	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—CCND1—sarcoma	2.32e-05	0.00379	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—JUN—sarcoma	2.32e-05	0.00378	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—CTNNB1—sarcoma	2.3e-05	0.00375	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—CXCR4—sarcoma	2.25e-05	0.00366	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	2.22e-05	0.00362	CbGpPWpGaD
Hydrocortisone—ANXA1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	2.17e-05	0.00354	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—PDGFRA—sarcoma	2.13e-05	0.00348	CbGpPWpGaD
Hydrocortisone—ABCG2—HIF-1-alpha transcription factor network—VEGFA—sarcoma	2.11e-05	0.00344	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL2—sarcoma	2.1e-05	0.00343	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TLE1—sarcoma	2.08e-05	0.0034	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—sarcoma	2.06e-05	0.00337	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—JUN—sarcoma	2.04e-05	0.00333	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	1.98e-05	0.00323	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—CREB1—sarcoma	1.96e-05	0.00321	CbGpPWpGaD
Hydrocortisone—ANXA1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	1.89e-05	0.00308	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—MYC—sarcoma	1.86e-05	0.00304	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	1.81e-05	0.00296	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—VEGFC—sarcoma	1.76e-05	0.00287	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—CREB1—sarcoma	1.7e-05	0.00277	CbGpPWpGaD
Hydrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	1.66e-05	0.00271	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—FUS—sarcoma	1.54e-05	0.00251	CbGpPWpGaD
Hydrocortisone—NR3C1—AP-1 transcription factor network—TP53—sarcoma	1.53e-05	0.0025	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—ENO2—sarcoma	1.43e-05	0.00233	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—HBA1—sarcoma	1.42e-05	0.00232	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—FLT1—sarcoma	1.4e-05	0.00229	CbGpPWpGaD
Hydrocortisone—NR3C1—Adipogenesis—CTNNB1—sarcoma	1.4e-05	0.00229	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PLCG1—sarcoma	1.38e-05	0.00225	CbGpPWpGaD
Hydrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—sarcoma	1.35e-05	0.0022	CbGpPWpGaD
Hydrocortisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	1.33e-05	0.00217	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CXCR4—sarcoma	1.33e-05	0.00216	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—ATF1—sarcoma	1.31e-05	0.00214	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	1.31e-05	0.00213	CbGpPWpGaD
Hydrocortisone—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	1.23e-05	0.00202	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—ENO2—sarcoma	1.23e-05	0.00201	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—HBA1—sarcoma	1.22e-05	0.002	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—JUN—sarcoma	1.22e-05	0.00199	CbGpPWpGaD
Hydrocortisone—CYP11B2—Metabolism—PLCG1—sarcoma	1.21e-05	0.00198	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—sarcoma	1.21e-05	0.00198	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—CREB1—sarcoma	1.2e-05	0.00196	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—IL2—sarcoma	1.16e-05	0.0019	CbGpPWpGaD
Hydrocortisone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	1.14e-05	0.00186	CbGpPWpGaD
Hydrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—sarcoma	1.07e-05	0.00174	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	1.05e-05	0.00172	CbGpPWpGaD
Hydrocortisone—CYP11B1—Metabolism—PLCG1—sarcoma	1.04e-05	0.0017	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—IGF1R—sarcoma	1.03e-05	0.00168	CbGpPWpGaD
Hydrocortisone—ABCB1—Allograft Rejection—VEGFA—sarcoma	9.88e-06	0.00161	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—FOXO1—sarcoma	9.79e-06	0.0016	CbGpPWpGaD
Hydrocortisone—ANXA1—GPCR downstream signaling—IL2—sarcoma	9.79e-06	0.0016	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PDGFRB—sarcoma	9.78e-06	0.0016	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—PDGFRA—sarcoma	9.63e-06	0.00157	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—IL2—sarcoma	8.89e-06	0.00145	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—KDR—sarcoma	8.1e-06	0.00132	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	7.76e-06	0.00127	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—ENO2—sarcoma	7.72e-06	0.00126	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—HBA1—sarcoma	7.67e-06	0.00125	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—KIT—sarcoma	7.46e-06	0.00122	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—NRAS—sarcoma	7.46e-06	0.00122	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CREB1—sarcoma	7.1e-06	0.00116	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—EGFR—sarcoma	6.8e-06	0.00111	CbGpPWpGaD
Hydrocortisone—SLCO1A2—Metabolism—PLCG1—sarcoma	6.55e-06	0.00107	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—KRAS—sarcoma	6.42e-06	0.00105	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	6.42e-06	0.00105	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—ENO2—sarcoma	6.11e-06	0.000997	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—HBA1—sarcoma	6.07e-06	0.000991	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—ENO2—sarcoma	6.06e-06	0.000988	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—HBA1—sarcoma	6.02e-06	0.000982	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MDM2—sarcoma	5.88e-06	0.000959	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	5.59e-06	0.000912	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	5.58e-06	0.00091	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	5.54e-06	0.000903	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling by GPCR—HRAS—sarcoma	5.46e-06	0.000891	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—IL2—sarcoma	5.25e-06	0.000857	CbGpPWpGaD
Hydrocortisone—ABCG2—Metabolism—PLCG1—sarcoma	5.18e-06	0.000846	CbGpPWpGaD
Hydrocortisone—CYP3A7—Metabolism—PLCG1—sarcoma	5.14e-06	0.000839	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CCND1—sarcoma	5.12e-06	0.000835	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—JUN—sarcoma	5.11e-06	0.000834	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—CTNNB1—sarcoma	5.07e-06	0.000827	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	5e-06	0.000817	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	4.87e-06	0.000795	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—SRC—sarcoma	4.58e-06	0.000748	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	4.48e-06	0.000732	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—VEGFA—sarcoma	4.46e-06	0.000728	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—NRAS—sarcoma	4.41e-06	0.000719	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	4.39e-06	0.000716	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—ENO2—sarcoma	4.38e-06	0.000714	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—HBA1—sarcoma	4.35e-06	0.00071	CbGpPWpGaD
Hydrocortisone—NR3C1—Generic Transcription Pathway—MYC—sarcoma	4.15e-06	0.000677	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	4.14e-06	0.000676	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—MYC—sarcoma	4.11e-06	0.00067	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—EGFR—sarcoma	4.02e-06	0.000655	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—KRAS—sarcoma	3.79e-06	0.000619	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—ENO2—sarcoma	3.79e-06	0.000619	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—HBA1—sarcoma	3.77e-06	0.000615	CbGpPWpGaD
Hydrocortisone—CYP3A5—Metabolism—PLCG1—sarcoma	3.71e-06	0.000606	CbGpPWpGaD
Hydrocortisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	3.68e-06	0.000601	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—TP53—sarcoma	3.37e-06	0.00055	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—ENO2—sarcoma	3.3e-06	0.000539	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—HBA1—sarcoma	3.28e-06	0.000536	CbGpPWpGaD
Hydrocortisone—ANXA1—Signaling Pathways—HRAS—sarcoma	3.23e-06	0.000526	CbGpPWpGaD
Hydrocortisone—CYP2C8—Metabolism—PLCG1—sarcoma	3.22e-06	0.000525	CbGpPWpGaD
Hydrocortisone—ABCB1—Metabolism—PLCG1—sarcoma	2.8e-06	0.000457	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—ENO2—sarcoma	2.04e-06	0.000332	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—HBA1—sarcoma	2.02e-06	0.00033	CbGpPWpGaD
Hydrocortisone—NR3C1—Gene Expression—MYC—sarcoma	2e-06	0.000326	CbGpPWpGaD
Hydrocortisone—CYP3A4—Metabolism—PLCG1—sarcoma	1.73e-06	0.000282	CbGpPWpGaD
